New once-daily formula combines pine bark extract, tamarind, chlorella, ginkgo biloba, spirulina, lion’s mane mushroom, bacopa monnieri, moringa and neem, with an ingredient-by-ingredient research overview
AURORA, Colo., Sept. 19, 2026 — JointVive today announced the U.S. launch of its nine-ingredient daily liquid drop supplement formulated to support joint comfort and mobility wellness in adults. The once-daily liquid formula combines botanical extracts, marine-derived algae, a functional mushroom and plant-based compounds, delivered in a liquid drop format that can be taken directly or added to water, tea, coffee or juice. It is designed for adults who want a single daily supplement that fits into an established routine of balanced nutrition, physical activity and regular healthcare.
The formula contains pine bark extract, tamarind, chlorella, ginkgo biloba, spirulina, lion’s mane mushroom (Hericium erinaceus), bacopa monnieri, moringa and neem. The recommended serving is one drop per day, preferably in the morning, taken directly or added to any beverage. The bottle should be shaken well before each use. JointVive is manufactured as a natural, plant-based, non-GMO, stimulant-free formula with no synthetic additives, produced in a GMP-certified facility.
Alongside the launch, JointVive is publishing an ingredient overview that summarizes published research on each component. The overview also explains where that research stops and what it does not establish about the finished product.
“Joint comfort and mobility supplements are often sold on bold promises built from loosely connected studies,” said Ryan Phillippe, Media Relations Manager at JointVive. “We took the opposite approach. JointVive is a straightforward daily formula, and we’re telling consumers exactly what’s in it, what the science on each ingredient actually shows, and where the evidence is still limited.”
A Multi-Ingredient Formula for Daily Joint Comfort and Mobility Wellness
JointVive’s formula draws from four ingredient categories, each associated with different aspects of normal physiological function:
- Antioxidant and anti-inflammatory botanicals: Pine bark extract and ginkgo biloba contribute polyphenolic compounds that have been studied in the context of antioxidant activity and normal inflammatory balance — both recognized as relevant to normal joint tissue health.
- Connective tissue and comfort support: Tamarind and bacopa monnieri contribute bioactive compounds that have been studied in the context of normal connective tissue function, joint comfort and cognitive wellness respectively.
- Nutrient-dense algae: Chlorella and spirulina are freshwater microalgae recognized for their concentrated profiles of protein, vitamins, minerals and antioxidant pigments, and have been studied in the context of normal inflammatory balance and antioxidant activity.
- Botanical multi-nutrient compounds: Lion’s mane mushroom, moringa and neem contribute bioactive compounds with documented traditional use histories and active research profiles in the context of normal cellular health, normal inflammatory balance and antioxidant protection.
The combination reflects the company’s view that joint comfort and mobility wellness involves multiple interconnected systems — including antioxidant protection of joint tissue, normal inflammatory balance, connective tissue integrity and nutrient support — rather than a single pathway. JointVive emphasizes that this is a formulation rationale, not a clinical finding. The finished product has not been evaluated as a complete formula in published clinical trials.
Pine Bark Extract: Research on Antioxidant Activity and Joint Comfort
Pine bark extract (Pinus pinaster) is derived from the bark of the maritime pine tree and is standardized to contain oligomeric proanthocyanidins (OPCs) — a class of polyphenolic compounds with antioxidant properties that have attracted substantial scientific research interest. The most studied commercial form is Pycnogenol®, though pine bark extracts vary in their standardization and bioactive profiles.
A 2020 Cochrane systematic review on pine bark extracts for chronic conditions noted that while some individual trials had observed associations with improvements in self-reported joint comfort markers, the overall evidence was insufficient to support therapeutic claims, citing small study sizes, variable preparations and inconsistent outcome measures.
These studies had important limits — specific standardized extracts, defined populations, controlled conditions — and their findings do not establish outcomes from the finished JointVive formula. Its inclusion reflects the recognized antioxidant research profile of pine bark OPCs and active scientific interest in their relationship to normal joint tissue health, not a product-specific clinical claim.
Tamarind: Research on Joint Comfort and Connective Tissue Support
Tamarind (Tamarindus indica) is a tropical tree whose fruit pulp and seed extracts have been used in traditional Ayurvedic and African medicine. Its bioactive compounds include polyphenols, organic acids and tamarind seed polysaccharide (TSP) — a compound that has attracted research interest for its relationship to normal joint tissue lubrication and connective tissue function.
Research on tamarind seed extract has examined its relationship to glycosaminoglycan metabolism and synovial fluid markers in laboratory and animal models. A small number of clinical studies have examined tamarind-containing preparations in adults with joint-related concerns and observed associations with self-reported comfort markers. These studies had important limits — specific preparations, small populations, short durations — and their findings do not establish outcomes from the JointVive formula. Its inclusion reflects the recognized research profile of tamarind’s bioactive compounds in the context of normal connective tissue function, not a product-specific clinical claim.
Chlorella: Research on Antioxidant Activity and Normal Inflammatory Balance
Chlorella is a genus of single-celled freshwater green algae recognized for its concentrated nutritional profile, including complete protein, chlorophyll, vitamins B12 and D, iron and antioxidant carotenoids. It has been studied in the context of antioxidant activity, normal inflammatory balance and detoxification support across a range of research designs.
A systematic review examining chlorella supplementation in adults observed associations with improvements in antioxidant markers and reductions in certain inflammatory signaling markers in several study populations. These studies had important limits — specific chlorella preparations, defined populations, variable doses — and their findings describe how chlorella’s bioactive compounds interact with antioxidant and inflammatory markers, not outcomes from the finished JointVive formula. Its inclusion reflects the recognized nutritional and antioxidant research profile of chlorella, not a product-specific clinical claim.
Ginkgo Biloba: Research on Antioxidant Activity and Circulation
Ginkgo biloba leaf extract is among the most widely studied botanical ingredients globally. It contains flavone glycosides and terpenoids — plant compounds with antioxidant properties studied in the context of normal circulation, antioxidant protection and cognitive function. Its recognized antioxidant and circulatory research profile has made it a widely used ingredient in wellness formulations.
The evidence base for ginkgo biloba is broad but mixed across outcomes and populations. Findings from individual studies have not been uniformly replicated, and systematic reviews have returned varied conclusions depending on the outcome examined. Ginkgo biloba can interact with anticoagulant and antiplatelet medications, including warfarin and aspirin. Individuals taking blood-thinning medications should consult a qualified healthcare professional before use.
These findings do not establish outcomes from the JointVive formula. Its inclusion reflects the recognized antioxidant and circulatory research profile of ginkgo biloba, not a product-specific clinical claim.
Spirulina: Research on Antioxidant Activity and Normal Inflammatory Balance
Spirulina is a cyanobacterium (blue-green microalgae) recognized for its concentrated nutritional density, including complete protein, B vitamins, iron, gamma-linolenic acid (GLA) and phycocyanin — a blue pigment with antioxidant properties. It has been studied across a range of research contexts, including antioxidant activity, normal inflammatory balance and immune support.
A systematic review and meta-analysis published in a peer-reviewed nutrition journal observed associations between spirulina supplementation and improvements in antioxidant markers and reductions in certain inflammatory signaling markers in adult participants. Reviewers noted variability in study quality, spirulina dose and preparation as limiting factors. These findings describe how spirulina’s bioactive compounds interact with antioxidant and inflammatory markers in controlled conditions and do not establish outcomes from the JointVive formula. Its inclusion reflects the recognized nutritional and antioxidant research profile of spirulina, not a product-specific clinical claim.
Lion’s Mane Mushroom: Research on Neural and Gut-Related Wellness Markers
Lion’s mane (Hericium erinaceus) is an edible and medicinal mushroom used in traditional East Asian medicine. Its bioactive compounds — hericenones and erinacines — have attracted scientific interest for their relationship to normal neural function and gut lining integrity. While lion’s mane is primarily studied in neurological and digestive wellness contexts, its broader antioxidant profile and gut-brain axis research have contributed to its inclusion in multi-ingredient wellness formulations.
Laboratory and animal studies have observed effects of lion’s mane compounds on neural growth factor activity and gut epithelial cell markers. Human clinical evidence remains limited in volume and methodological quality. A 2020 Cochrane systematic review noted that evidence for many botanical and fungal preparations remained insufficient to support therapeutic claims, citing small study sizes and inconsistent outcome measures. Its inclusion reflects the recognized traditional use history of lion’s mane and emerging scientific interest in its bioactive compounds, not a product-specific clinical claim.
Bacopa Monnieri: Research on Cognitive Function and Normal Inflammatory Balance
Bacopa monnieri is a herbaceous plant used in Ayurvedic medicine for centuries, primarily in the context of cognitive support. Its principal bioactive compounds — bacosides — have been studied for their relationship to normal neurotransmitter activity, antioxidant protection of neural tissue and, more recently, normal inflammatory balance. Research on bacopa’s antioxidant and anti-inflammatory properties in peripheral tissue, including joint-adjacent tissues, remains a developing area of investigation.
A systematic review of randomized controlled trials examining bacopa supplementation in adults observed associations with improvements in cognitive performance markers compared with placebo. These studies used specific standardized bacopa preparations in defined populations, and their findings describe cognitive marker outcomes from isolated bacopa, not outcomes from the JointVive formula. Its inclusion reflects the recognized antioxidant and research profile of bacosides and their potential relevance to normal inflammatory balance, not a product-specific clinical claim.
Moringa: Research on Antioxidant Activity and Normal Inflammatory Balance
Moringa (Moringa oleifera) is a tree native to South Asia whose leaves are recognized for their concentrated nutrient and phytochemical content, including isothiocyanates, flavonoids, polyphenols, vitamin C, beta-carotene and complete protein. It has been studied in the context of antioxidant activity, normal inflammatory balance and a broad range of physiological markers.
Laboratory and animal studies have examined moringa leaf extracts for their antioxidant and normal inflammatory balance properties across a range of tissue types. Human clinical evidence on moringa supplementation is more limited in volume and methodological consistency, with most available trials being of short duration and modest sample size. Its inclusion in JointVive reflects the recognized antioxidant and phytochemical research profile of moringa leaf, not a product-specific clinical claim.
Neem: Research on Antioxidant Activity and Normal Cellular Health
Neem (Azadirachta indica) is a tree native to South Asia whose leaves, bark and seeds have been used for centuries in traditional Ayurvedic medicine. Its bioactive compounds — including nimbolide, azadirachtin and quercetin — have been studied for their antioxidant properties and relationship to normal cellular health and normal inflammatory balance.
Laboratory and animal studies have examined neem extracts in the context of antioxidant activity and normal inflammatory signaling. Human clinical evidence on neem supplementation as a standalone ingredient in joint wellness contexts is limited. Its inclusion in JointVive reflects its established traditional use history and antioxidant research profile, complementing the formula’s broader cellular health and normal inflammatory balance rationale, not a product-specific clinical claim.
What Ingredient Research Does and Does Not Show
JointVive’s research overview separates three questions: what each ingredient is, what researchers have studied about it, and what has been demonstrated about the finished formula. Those questions have different answers.
The studies referenced here examined individual ingredients at specific doses, in specific populations and over specific periods. JointVive combines nine ingredients in a single daily liquid drop, and the amounts, preparations and interactions within that formula differ from the conditions of any individual study. For that reason, JointVive does not describe its formula as clinically proven and does not attribute ingredient-level research results to the finished product.
“We think consumers respond better to honesty than hype,” said Ryan Phillippe. “Every ingredient in JointVive has a recognized nutritional role or an active research profile. What we won’t do is stretch a study beyond what it found.”
Safety and Suitability
JointVive is intended for healthy adults. Individuals who are taking prescription medication — particularly anticoagulants, antiplatelet drugs or blood pressure medication — should consult a qualified healthcare professional before use. This is particularly relevant given that ginkgo biloba and neem in this formula have each been associated with potential interactions with blood-thinning agents. The same consultation applies to individuals who are pregnant, nursing, managing a medical condition, scheduled for surgery or taking other dietary supplements.
Shake the bottle well before each serving. Consumers should follow the directions on the product label and should not exceed the recommended serving. The physical label and Supplement Facts panel are the definitive source for ingredient amounts, directions and warnings.
Product Format and Availability
JointVive is available now to consumers across the United States through the company’s official website. The formula is delivered as a once-daily liquid drop, taken directly or added to any beverage. The product is manufactured as a natural, plant-based, non-GMO, stimulant-free formula in a GMP-certified facility.
Under U.S. federal law, dietary supplements are not subject to pre-market FDA approval. GMP certification covers manufacturing process standards and quality controls and does not constitute endorsement of the product or its claims by the FDA.
About JointVive
JointVive was developed with the principle that joint comfort and mobility wellness supplements should be formulated from ingredients with documented research histories, disclosed transparently and represented accurately — without overstating what individual ingredient studies show about a finished multi-ingredient formula.
The company’s mission is to offer adults a daily joint wellness option that draws on recognized botanical and nutritional research traditions, manufactured to verifiable quality standards and supported by honest communication about what the science does and does not establish. Every ingredient in JointVive is selected on the basis of its published research profile or its recognized nutritional role.
JointVive holds itself to three standards: complete ingredient disclosure on the Supplement Facts label, manufacturing in a GMP-certified facility, and accurate representation of the science behind each component — including its limits.
JointVive’s formula combines pine bark extract, tamarind, chlorella, ginkgo biloba, spirulina, lion’s mane mushroom, bacopa monnieri, moringa and neem in a once-daily liquid drop. The formula is natural, plant-based, non-GMO and stimulant-free. More information is available at jointvive.com.
References
- Robertson NU, Schoonees A, Brand A, Visser J. Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database of Systematic Reviews. 2020;9:CD008294.
- Bhadoriya SS, Ganeshpurkar A, Bhadoriya R, Patel JR. Tamarindus indica: extent of explored potential. Pharmacognosy Reviews. 2011;5(9):73–81.
- Panahi Y, Darvishi B, Jowzi N, et al. Chlorella vulgaris: a multifunctional dietary supplement with diverse medicinal properties. Current Pharmaceutical Design. 2016;22(2):164–173.
- National Institutes of Health, Office of Dietary Supplements. Ginkgo: Fact Sheet for Health Professionals.
- Finamore A, Palmery M, Bensehaila S, Peluso I. Antioxidant, immunostimulating, and microbial properties of spirulina. Oxidative Medicine and Cellular Longevity. 2017;2017:3247528.
- Mori K, Inatomi S, Ouchi K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research. 2009;23(3):367–372.
- Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology. 2014;151(1):528–535.
- Mbikay M. Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia and dyslipidemia: a review. Frontiers in Pharmacology. 2012;3:24.
- Sharma C, Vas AJ, Goala P, et al. Ethanolic neem (Azadirachta indica) leaf extract prevents growth of MCF-7 and HeLa cells and potentiates the therapeutic index of cisplatin. Journal of Oncology. 2014.
Media Contact
Ryan Phillippe, Media Relations Manager
JointVive
19655 E 35th Dr #100, Aurora, CO 80011, USA
Email: support@jointvive.com
Phone: 1-800-390-6035
Website: jointvive.com
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research cited in this release pertains to individual ingredients studied in isolation; it does not represent clinical evaluation of the JointVive formula as a finished product, nor does it constitute endorsement by the referenced researchers, journals or institutions.
The post JointVive Reviews: Launches Nine-Ingredient Daily Liquid Drop Supplement for Joint Comfort and Mobility Wellness in the U.S. appeared first on 24 Health Times.
